The transcription factor E2F-1 plays a pivotal role in the regulation of G1/S transition in higher eukaryotes cell cycle. We used a cell line containing an inducible E2F-1 and oligonucleotide microarray analysis to identify novel E2F target genes. We show that E2F-1 up-regulates the expression of a number of genes coding for components of the DNA replication machinery. Among them is the gene coding for the 32 Kd subunit of replication protein A (RPA2). Replication protein A is the most abundant single strand DNA binding complex and it is essential for DNA replication. We demonstrate that RPA2 is a novel E2F target gene whose expression can be directly regulated by E2F-1 via E2F binding sites in its promoter. In addition, expression of Topoisomerase IIa and subunit IV of DNA polymerase a is also up-regulated upon E2F-1 induction. Taken together, these results provide novel links between components of the DNA replication machinery and the cell growth regulatory pathway involving the Rb tumor suppressor and E2F. Oncogene (2001) 20, 1379 ± 1387.
Introduction
E2F transcription factors play a pivotal role in the control of cell cycle progression and regulate the expression of genes required for G1/S transition (Dyson, 1998; Muller and Helin, 2000) . The DNA binding complex named E2F is a heterodimeric complex consisting of an E2F component and a dimerization partner, DP. To date, six E2F genes and two DP genes have been isolated (Dyson, 1998) . E2F activity is modulated by multiple mechanisms including negative regulation by interaction with the product of the Rb tumor suppressor gene, RB, and its related proteins p107 and p130 (reviewed in Dyson, 1998) . Binding of RB family members to E2F results in active transcriptional repression of E2F regulated genes and growth suppression. During late G1 phosphorylation of RB family members by cyclin dependent kinases results in release of E2Fs from the complex, leading to activation and/or derepression of E2F target genes (Kaelin, 1999) . This, in turn, leads to cell cycle progression. The importance of the RB/E2F pathway in controlling cell growth is emphasized by frequent inactivation of the Rb gene or its upstream regulators, cyclin D, Cdk4 and p16, in human tumors (Hall and Peters, 1996; Sherr, 1996; Weinberg, 1995) .
Known E2F regulated genes are involved in nucleotide synthesis, recognition of origins of replication, DNA replication and control of cell cycle progression (Helin, 1998) . In agreement with the regulation of many growth related genes by E2F, ectopic expression of E2F-1, 2 or 3 is sucient to induce S phase entry of quiescent immortal rodent cells (Johnson et al., 1993; Qin et al., 1994; Shan and Lee, 1994; Vigo et al., 1999) . Furthermore, overexpression of E2F-1 and its heterodimeric partner DP-1 together with activated ras leads to transformation of primary rodent cells (Johnson et al., 1994) . More recent studies show that double transgenic mice over-expressing E2F-1 and activated ras in their epidermis develop skin tumors (Pierce et al., 1998) . Thus, E2F-1 contributes to tumorigenesis in vivo and it therefore functions, at least in some settings, as an oncogene.
DNA replication is a complex process involving numerous proteins yet only four of them, DNA polymerase a subunit I and II, proliferating cell nuclear antigen (PCNA) and DNA polymerase d catalytic subunit have so far been recognized as the products of E2F target genes (Lee et al., 1995; Nishikawa et al., 2000; Pearson et al., 1991; Zhao and Chang, 1997) .
In this study we used a cell line containing an inducible E2F-1 and DNA array hybridization to identify additional E2F target genes. We show that E2F-1 up-regulates the expression of six new genes encoding proteins that participate in DNA replication, among them are the genes encoding for the 32 Kd subunit of replication protein A (RPA2), Topoisomerase IIa and subunit IV of DNA polymerase a. Their expression is E2F responsive and in the case of RPA2 this E2F responsiveness depends on the E2F binding sites in its promoter.
Results

Analysis of up-regulated genes after E2F-1 induction
In an attempt to identify new E2F target genes we used a Rat-1a derived cell line containing a stably integrated Zinc inducible E2F-1, Rat-1-MT-wtE2F-1 (Qin et al., 1994) . Upon addition of ZnCl 2 (100 mM) to quiescent Rat-1-MT-wtE2F-1 cells, E2F-1 protein level is elevated and the cells enter S phase and later undergo apoptosis (Qin et al., 1994) . When these cells were kept for 48 h in medium with 0.1% serum they entered quiescence, as determined by FACS analysis (data not shown). Under these conditions, addition of ZnCl 2 (100 mM) resulted in a rapid and signi®cant elevation of E2F-1 protein level. E2F-1 protein level was increased 3 h after ZnCl 2 addition and it remained high for at least 12 h (Figure 1 ). Total RNA was extracted from Rat-1-MT-wtE2F-1 arrested cells before and after E2F-1 induction in two independent experiments. In one experiment the RNA was extracted 12 h after E2F-1 induction and in the other at two time points after E2F-1 induction: 12 and 16 h. These RNAs were used to prepare probes to screen an Aymetrics Rat DNA microarrays (Rat Genome U34A array) containing 8700 cDNAs and ESTs. RNA extracted from arrested cells before and 12 h after E2F-1 induction was also used to probe an Atlas membrane containing 588 rat cDNAs (Clontech, 7738-1). In the screen of the Aymetrics Rat DNA microarrays, out of the 8700 genes present on each chip expression of 35 genes and 10 ESTs was reproducibly increased more than twofold upon E2F-1 induction. Seven of the 35 induced genes were known E2F target genes ± Cyclin E, PCNA, Thymidylate synthase, DNA polymerase a subunit II, DNA polymerase d catalytic subunit, MCM6 and MCM2. Among the other induced genes, not described previously as E2F target genes, a most evident functional group of genes included six genes involved in DNA replication, a cellular process known to be regulated by E2F-1 (Table 1 ).
In the screen of Atlas membrane expression of two known E2F target genes present on the membrane, cyclin E and PCNA, was increased upon E2F-1 induction (Figure 2 ). In addition, expression of several genes including the gene encoding for the 32 Kd subunit of replication protein A, RPA2, was similarly induced (Figure 2 ). Computerized analysis of the data, performed using AtlasImage 1.01 software (Clontech, USA), demonstrated that the induction of expression of RPA2, cyclin E and PCNA was 3.48-, 2.14-and 1.2-fold, respectively. Figure 1 The kinetic of expression of inducible E2F-1 in quiescent rat cells. Rat-1a-1093 Rat-1a- (1093 and Rat-1a-MT-wtE2F-1 (wt E2F-1) cells were kept for 48 h in medium containing 0.1% serum and then 100 mM ZnCl 2 was added. At the times indicated at the top of each lane (in hours), cells were harvested and cell extracts were used for Western blot analysis with an anti E2F-1 monoclonal antibody (SQ41). Molecular size markers in kilodaltons are shown on the left (Erdile et al., 1990; Kenny et al., 1990) . RPA is a heterotrimer composed of 70 (RPA1), 32 (RPA2) and 14 Kd (RPA3) subunits (Fairman and Stillman, 1988; Wold and Kelly, 1988) . The DNA chip analysis indicated that expression of the RPA2 gene was reproducibly elevated upon E2F-1 induction (Table 1 ) and similar elevation was detected using the Atlas membrane. Therefore we further investigated the regulation of its expression by E2F-1. Elevation of RPA2 mRNA levels upon E2F-1 induction was detected also by RT ± PCR analysis ( Figure 3a) and Northern blot analysis (data not shown). To investigate whether this E2F-1 induced activation of RPA2 expression requires a transcriptionally active E2F-1 we utilized a Rat-1 derived cell line containing a stably integrated Zinc inducible E2F-1 mutant, Rat-1-MT-E2F-1dlTA. This E2F-1 mutant lacks the transactivation domain and, therefore, can not transactivate gene expression. Upon addition of Zinc to this cell line protein levels of E2F-1dlTA were comparable to those of wtE2F-1 in Rat-1-MT-wtE2F-1 following Zinc addition (Figure 3b ). However, this did not lead to an increase in RPA2 expression (Figure 3a ). This result demonstrates that RPA2 gene expression is not induced in response to the Zinc addition itself and that a transcriptionaly functional E2F-1 is required for this induction. To test whether expression of RPA2 changes as arrested cells resume growth, cells of Rat-1-1093 (containing the empty vector), Rat-1-MT-wtE2F-1 cell lines and the human glioblastoma cell line T98G were growth arrested at G1 by serum starvation and then allowed to resume growth by addition of serum. Growth arrest and resumption of growth were veri®ed by FACS analysis (data not shown). Under these conditions, RPA2 mRNA levels were induced in all three cell lines 12 h after serum addition (Figure 3c ), demonstrating that RPA2 gene expression is growth regulated. Induction of E2F-1 expression in quiescent Rat-1-MT-wtE2F-1 cells leads to S phase entry ( (Qin et al., 1994) and Figure 4 ). Therefore, up-regulation of RPA2 expression may be an indirect consequence of E2F-1-induced cell cycle progression. To address this possibility we tested whether RPA2 up-regulation precedes E2F-1-induced S phase entry. As can be seen in Figure  4 , RPA2 mRNA levels are increased already 6 h after E2F-1 induction while cell cycle distribution of the cells at this time does not dier signi®cantly than that of uninduced cells. At 12 h post induction S phase entry is evident and RPA2 mRNA levels are further increased. Thus, RPA2 induction precedes S phase entry indicating that the former is not an indirect consequence of the latter. The RPA2 gene and its upstream sequence are available as part of the Human Genome project. To further study the regulation of RPA2 expression by E2F-1 we determined the position of its transcription start site by performing a 5' rapid ampli®cation of cDNA ends (race) using Gibco ± BRL 5'RACE kit (18374-054). As shown in Figure 5a , a PCR reaction using an oligonucleotide located 588 bp downstream to Figure 2 Dierential hybridization of atlas rat array. Total RNA prepared from growth arrested Rat-1a-MT-wtE2F-1 cells before and after 12 h induction with 100 mM ZnCl 2 was used to generate cDNA. Radiolabeled cDNA was hybridized to the Clontech Atlas membranes (7738-1). An enlargement of part of the membranes is presented. Each cDNA is present on the ®lter on two adjacent spots. Three of the genes which were upregulated upon induction of E2F-1 are indicated by arrows Figure 3 RPA2 expression is upregulated by E2F-1 and by serum. (a) RPA2 mRNA levels are upregulated by E2F-1. Rat-1-MT-wtE2F-1 (wtE2F-1) and Rat-1-MT-E2F-1dlTA (E2F-1dlTA) cells were kept in medium with 0.1% serum for 48 h and then cells were treated with 100 mM ZnCl 2 for 12 h (+) or not treated (7) prior to RNA extraction. Total RNA was used for RT ± PCR analysis using RPA2 and GAPDH speci®c oligonucleotides. (b) Cells were treated as in a and then lysed and subjected to Western blot analysis using an anti E2F-1 monoclonal antibody (Santa Cruz, sc-251). (c) RPA2 mRNA levels are upregulated by serum in both Rat and Human cells. Rat-1a-1093 (1093), Rat-1a-MTwtE2F-1 (wt E2F-1) and T98G cells were kept in medium with 0.1% FCS for 48 h and then serum was added to a ®nal concentration of 15%. Cells were lysed at the indicated times (in hours) after serum addition, RNA was extracted and subjected to RT ± PCR analysis using RPA2 and GAPDH speci®c oligonucleotides the 5' end of the previously published RPA2 cDNA (Erdile et al., 1990 ) gave rise to a single fragment of 631 bp. Sequencing of this PCR product demonstrated that it contains 53 additional bases upstream to the 5' end of the published human RPA2 cDNA. Comparison of the sequence of the PCR product to the genomic fragment containing the RPA2 gene clearly indicated that the additional 53 bases are positioned immediately upstream to the 5' end of the published cDNA. The 5' end of our 5'-race product is therefore used as the +1 reference point ( Figure 5 ) and the RPA2 promoter lies upstream to it. An examination of the RPA2 promoter region revealed four putative E2F DNA binding sites at positions 7125/7118,7320/7313,7309/7316 and 7406/7399. The site at 7320/7313 matches perfectly with the E2F consensus binding sequence and the other three sites dier from the consensus at one position but are identical to E2F sites in known E2F responsive promoters ( Figure 5 ). Computer analysis of the 700 bp sequence upstream to the transcription start site identi®ed additional potential binding sites of SP1 and ATF1. As for many of the known E2F target genes, the RPA2 promoter is TATA-less. A 682 bp fragment spanning the RPA2 promoter from +55 to 7627 was synthesized by PCR using human placenta genomic DNA as a template and was cloned in pA3Luc resulting in RPA2(7627/+55)Luc. Transient transfection of RPA2(7627/+55)Luc into cells of the human lung carcinoma cell line H1299 resulted in a luciferase activity which was 34-fold higher than that of the empty vector, pA3Luc, indicating that the cloned fragment is indeed a functional promoter (Figure 6 ). The role of E2F-1 in controlling the RPA2 promoter activity was then assessed by co-transfection of RPA2(7627/+55)Luc and E2F-1 and DP1 expression plasmids, into H1299 cells. This co-transfection resulted in an additional 2.5-fold increase in luciferase activity over the basal promoter activity (Figure 6 ), indicating that the RPA2 promoter is an E2F responsive promoter. No such increase was detected upon cotransfection of pA3Luc together with E2F-1 and DP1 ( Figure 6 ). To test whether the E2F DNA binding sites present in the RPA2 promoter are required for its E2F responsiveness, three of these sites were mutated using PCR-site directed mutagenesis to generate RPA2(Mut)Luc. Unlike the result obtained using RPA2(7627/ RNA was used for RT ± PCR analysis using RPA2 and GAPDH speci®c oligonucleotides E2F-1 up-regulates expression of DNA replication genes Y Kalma et al +55)Luc, when RPA2(Mut)Luc was transfected into H1299 cells its activity was not changed by coexpression of E2F-1 and DP1 ( Figure 6 ) demonstrating that the eect of E2F-1 on the RPA2 promoter activity is, most likely, a direct eect mediated by the E2F DNA binding sites. Similar results were obtained using another cell line, MCF-7 (data not shown). Interestingly, the basal activity of RPA2(Mut)Luc was somewhat higher than that of RPA2(7627/+55)Luc ( Figure  6 ) suggesting that the mutated sequences mediate also transcriptional repression.
Induction of Topoisomerase IIa and subunit IV of DNA polymerase a expression by E2F-1
Two of the DNA replication related genes whose expression was upregulated upon E2F-1 induction are the genes encoding for Topoisomerase IIa and subunit IV of DNA polymerase a. These genes were present twice on the DNA microarray, and they were induced in both cases (Table 1) , further validating their regulation by E2F-1. Elevation of mRNA levels of both genes upon E2F-1 induction was detected also by RT ± PCR analysis (Figure 7a ). Northern blot analysis demonstrated that mRNA levels of Topoisomerase IIa were elevated 12 h after addition of Zinc in Rat-1-MTwtE2F-1 cells but not in Rat-1-1093 cells (Figure 7b ) thus demonstrating that Topoisomerase IIa gene expression is not induced in response to the Zinc addition itself. It has been previously reported that mRNA levels of Topoisomearse IIa increase in S phase (Isaacs et al., 1998; Woessner et al., 1991) and we demonstrated that this is true also for Rat-1-1093 and Rat-1-MT-E2F-1 cells. When these cell lines were growth arrested at G1 by serum starvation and then allowed to resume growth by addition of 15% serum, Topoisomerase IIa mRNA levels were induced in both cell lines 12 h after serum addition (Figure 7b ) demonstrating that Topoisomerase IIa gene expression is growth regulated.
Discussion
Since the identi®cation of E2F-1 as an RB target a large body of evidence accumulated to support the idea that E2F-1 plays a critical role in regulating S phase entry. First, overexpression of E2F-1 in quiescent cells leads to S phase entry (Johnson et al., 1993; Kowalik et al., 1995) . Second, E2F regulates the expression of genes coding both for enzymes involved in nucleotide synthesis, such as thymidine kinase, thymidilate synthase, dihydrofolate reductase (DHFR), and for proteins which are components of the origin recognition complex such as Orc1, cdc6 and MCM2 to Figure 7 Expression of Topoisomerae IIa and DNA polymerase a subunit IV is up-regulated by E2F-1 (a) Topoisomerase IIa and DNA polymerase a subunit IV mRNA levels are upregulated by E2F-1. Rat-1a-MT-wtE2F-1 cells were kept in medium with 0.1% serum for 48 h and then cells were treated with (+) or without (7) 100 mM ZnCl 2 for 12 h prior to RNA extraction. Total RNA was used for RT ± PCR analysis using Topoisomerase IIa, DNA polymeraes a subunit IV and GAPDH speci®c oligonucleotides.
(b) Topoisomerase IIa mRNA levels are upregulated by serum in Rat cells. Rat-1a-1093 (1093) and Rat-1a-MT-wtE2F-1 (wtE2F-1) cells were kept in medium with 0.1% serum for 48 h and then treated by addition of either 100 mM ZnCl 2 (upper panel) or serum to a ®nal concentration of 15% (lower panel). Total RNA was prepared from cells at the indicated times (in hours) after ZnCl 2 or serum addition and subjected to Northern analysis using a Topoisomerase IIa probe. Acidic Ribosomal Protein (ARPP PO) was used as a control probe Figure 6 The RPA2 promoter is activated by E2F-1. H1299 cells were transiently transfected with 0.5 mg of pA3Luc (vector) or a RPA2(7627/+55)Luc (wtRPA2) or RPA2(Mut)Luc (mutRPA2), together with 0.5 mg of pCMV-b-GAL. 0.2 mg pCMV-E2F-1 and 0.2 mg pCMV-DP1 were added where indicated. Forty-two hours post transfection cell extracts were prepared and used for b-GAL and Luciferase assays. Fold of activation in the luciferase assay, after normalization for b-GAL activity, are depicted in the bar graph. Fold of activation is relative to the sample transected with pA3Luc
Oncogene E2F-1 up-regulates expression of DNA replication genes Y Kalma et al MCM7 Yan et al., 1998) . In addition, genes coding for components of the DNA replication machinery itself, such as DNA polymerase a subunits I and II, PCNA, and DNA polymerase d catalytic subunit are also E2F targets (Lee et al., 1995; Nishikawa et al., 2000; Pearson et al., 1991; Zhao and Chang, 1997) . DNA replication is a complex process and the proper expression and function of many proteins is required for its initiation as well as its successful completion. Taking into consideration the pivotal role played by E2F in controlling S phase entry it is reasonable to assume that many other genes coding for DNA replication proteins will be identi®ed as E2F targets.
Using RNA from a cell line with inducible E2F-1 as a probe for dierential screening of both an Atlas membrane and DNA chips we detected an increase in the expression of seven known E2F target genes: DNA polymerase a subunit II, DNA polymerase d catalytic subunit, PCNA, cyclin E, Thymidylate synthase, MCM6 and MCM2. In addition, we detected an increase in the expression of six replication related genes which were not described previously as E2F target genes. These are: (1) Topoisomerase IIa whose primary role is to disentangle interwined chromosomes during anaphase (reviewed in Isaacs et al., 1998); (2,3) Subunits III and IV of DNA polymerase a which constitute the DNA primase (reviewed in Foiani et al., 1997) ; (4) RF-C4, coding for the 37 Kd subunit of replication factor C (RF-C). RF-C is a complex consisting of ®ve proteins which binds the templateprimer junction thus recruiting DNA polymerases to the site of DNA synthesis (Mossi and Hubscher, 1998); (5) RPA2 encoding for the 32 Kd subunit of replication protein A which is the most abundant single strand DNA binding complex (reviewed in Iftode et al., 1999) and (6) Fen1, a 5'-3' exo/endonuclease essential for Okazaki fragments maturation (reviewed in Bambara et al., 1997) . These genes are depicted in Table 1. A comparison of our results with the comprehensive analysis of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae (Spellman et al., 1998) show that, in agreement with our ®ndings, most of the yeast homologues of the Rat genes presented in Table 1 are up-regulated in G1 phase of the cell cycle. These include the yeast homologues of DNA polymerase a subunit II, III and IV, DNA polymerase d catalytic subunit, PCNA, RF-C4, RPA2 and Fen1.
The E2F-dependent regulation of expression of three of the genes shown in Table 1 was further studied, resulting in the clear identi®cation of RPA2 as a new E2F-1 target gene. We also demonstrated that E2F-1 plays a role in the regulation of Topoisomerase IIa and DNA polymerase a subunit IV. RPA2 mRNA levels are induced both by E2F-1 and by serum and the RPA2 promoter contains four putative E2F binding sites. Our data clearly show that this promoter is activated by E2F-1 and mutations in three of the E2F binding sites abolish this activation.
The RPA2 gene codes for the 32 Kd subunit of replication protein A (RPA) which is a heterotrimeric protein complex (Fairman and Stillman, 1988; Wold and Kelly, 1988) . RPA is the most abundant ssDNA binding protein in eukaryotic cells. It can unwind dsDNA and it stabilizes DNA in the single strand conformation (Georgaki et al., 1992; Seroussi and Lavi, 1993; Treuner et al., 1996) and stimulates DNA synthesis by DNA polymerase a (Kenny et al., 1990) . RPA plays an essential role in DNA replication and mutations in RPA2 were found to be lethal to yeast (Philipova et al., 1996) . Importantly, an anti RPA2 antibody blocks the stimulation of DNA polymerase a by RPA and two distinct anti RPA2 monoclonal antibodies strongly inhibit SV40 DNA replication (Erdile et al., 1990; Kenny et al., 1990) . These data clearly demonstrate that the 32 Kd subunit of RPA, encoded by RPA2, is essential for DNA replication. Taken together with our results, these data strongly suggest that induction of RPA2 expression by E2F-1 contributes to E2F-1 induced DNA synthesis.
Little is known about the regulation of expression of the three RPA genes. However, experiments using S. cerevisia demonstrate that all three RPA genes are expressed in a cell cycle dependent manner and their mRNA levels peak at the G1/S boundary (Brill and Stillman, 1991) . The data presented here demonstrates that expression of at least one component of the RPA heterotrimer, RPA2, is cell cycle regulated also in higher eukaryotes. In addition to its regulation at the transcriptional level, RPA2 is phosphorylated in a cell cycle dependent fashion at the G1/S transition (Din et al., 1990; Fang and Newport, 1993) , and RPA association with origins of replication is regulated by cyclin and Dbf-4 dependent kinases (Tanaka and Nasmyth, 1998) . Thus, RPA2 is regulated in a cell cycle dependent manner both at the transcriptional and at the post-translational levels. Such a dual regulation is reminiscent of other E2F target genes such as cdc6 (Hateboer et al., 1998; Petersen et al., 1999; Yan et al., 1998) . The RPA1 gene was present neither on the Atlas membrane nor on the DNA chip used for this study. The RPA3 gene was also present on the DNA chip, however, its expression was only mildly increased upon E2F-1 induction: 2.6, 1.8 and 1.6 in experiments 0-12A, 0-12B and 0-16B depicted in Table 1 . Thus, it is not clear whether the co-regulation of the three RPA subunits exist also in higher eukaryotes and understanding the regulation of expression of the three RPA subunits requires additional studies.
It is noteworthy that RPA has been shown to recognize some types of damaged DNA, to interact with a number of proteins involved in DNA repair and to play a role in the response to DNA damage (He et al., 1995; Li et al., 1995; Nagelhus et al., 1997) . Recent reports demonstrate that E2F-1 protein level and DNA binding activity are induced upon DNA damage (Blattner et al., 1999; Hoerer et al., 1999; O'Connor and Lu, 1999) . Therefore, it is possible that E2F-1 regulates RPA2 expression not only when DNA E2F-1 up-regulates expression of DNA replication genes Y Kalma et al replication is required, i.e. before S phase, but also as part of the DNA damage response. Two other genes are demonstrated in the present report to be E2F responsive, namely Topoisomerase IIa and subunit IV of DNA polymerase a.
The latter encodes for the 48 Kd subunit of DNA polymerase a, which is the catalytic DNA primase subunit. It is sucient to synthesize in vitro the short RNA primers required to provide the 3' ends for elongation by DNA polymerase a (reviewed in Foiani et al., 1997) . DNA polymerase a has four subunits and its subunits I and II are known E2F target genes (Pearson et al., 1991; Nishikawa et al., 2000) . The gene encoding for subunit I was present on the DNA chip, however, its hybridization results were not informative. The genes encoding for subunits II and III were also present on the DNA chip and their expression was increased upon E2F-1 induction (Table 1 ). This raises the possibility that E2F co-regulates the four subunits of DNA pol a, that plays a major role in DNA replication and is the only enzyme that can initiate DNA chains de novo.
The Topoisomerase IIa gene codes for a 170 Kd protein whose primary role is to disentangle interwined chromosomes during anaphase (Isaacs et al., 1998) . The Topoisomerase IIa promoter shares some structural similarities with other cell cycle-regulated promoters such as Thymidine kinase, DHFR and DNA polymerase a subunit I. However, it does not contain E2F binding sites, and previous studies have shown that, unlike many E2F target genes, its mRNA expression peaks in late S rising to about 10-fold higher than in G1 (Isaacs et al., 1998; Woessner et al., 1991) . These data suggest that the E2F dependent increase detected in expression of Topoisomerase IIa is most probably indirect. This is in agreement with the presence of a myb binding site within the Topoisomerase IIa promoter (Isaacs et al., 1998) and the ability of Bmyb, a known E2F target gene (Lam and Watson, 1993) , to up-regulate expression of Topoisomerase IIa. Irrespectively of the mechanism by which Topoisomerase IIa is up-regulated in response to E2F induction, this is an interesting phenomenon, especially since Topoisomerase IIa is the primary cellular target of the most widely used anti-neoplastic agents including doxorubicin, etoposide and mitoxantrone. It has been documented that Topoisomerase IIa mRNA levels are higher in a variety of tumors in comparison to adjacent normal tissue (Hasegawa et al., 1993; Isaacs et al., 1998) . It would be interesting to test whether tumorrelated mutations in the RB/E2F pathway result in changes in the levels of Topoisomerase IIa, and whether this is re¯ected in the responsiveness of the tumor to anti-neoplastic treatment with inhibitors of Topoisomerase IIa.
The ability of E2F-1 to up-regulate the expression of a number of genes coding for components of the DNA replication machinery provide novel links between components of the DNA replication machinery and the cell growth regulatory pathway involving RB and E2F. DNA replication is a complex process involving numerous proteins and the genes coding for many of them were not present on the DNA chips analysed here. The full spectrum of replication related genes that are regulated, either directly or indirectly, by E2Fs awaits additional studies.
Materials and methods
Cell culture
Rat-1a ®broblasts that had stably integrated the p1093, p1093-E2F-1 or p1093-E2F-1d1TA were grown in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% (vol/vol) fetal calf serum (FCS) and G418 (500 mg/ml). T98G and MCF-7 cells were grown in DMEM supplemented with 10% (vol/vol) fetal bovine serum (FBS). H1299 cells were grown in RPMI supplemented with 10% (vol/vol) FCS.
Western blotting
Cells were lysed in lysis buer [20 mM HEPES pH 7.8, 450 mM NaCl, 25% glycerol, 0.2 mM EDTA, 0.5 mM DTT, phenylmethylsulfonyl¯uoride (43 mg/ml), aprotinin (17 mg/ ml), leupeptin (22 mg/ml)]. Twenty mg of protein from each lysate, as determined by Bradford assay, were resolved by electrophoresis in a SDS 10% polyacrylamide gel and transferred to ®lters (Protran BA, 85, S&S). Filters were incubated with the indicated antibodies over night after 2 h incubation in PBS with 0.05% Tween and 5% dry milk. Binding of the primary antibodies was detected using an enhanced chemiluminescence kit (ECL Amersham).
Screening of atlas cDNA expression array
Rat-1-MT-E2F-1 cells were kept for 48 h in DMEM containing 0.1% FCS. Half of the cells were treated with 100 mM ZnCl 2 for 12 h and then cells were harvested and total RNA was extracted using Tri Reagent method (Molecular, Research Center). After DNase treatment radiolabeled cDNA was prepared from 9 mg of total RNA and hybridized to the membranes (Clontech, 7738-1) according to the manufacturer's instructions. Computerized analysis of the data was performed using AtlasImage 1.01 software (Clontech, USA). The signal intensities were normalized globally using the sum method (AtlasImage Clontech, USA).
DNA chip
RNA was extracted as described for the Atlas cDNA expression array and double strand cDNA was synthesized by Reverse Transcription. Biotin-labeled cRNA was produced from the cDNA and used to probe Aymetrics Rat DNA micro-array (Rat Genome U34A array). Hybrydization and washes were performed using Aymetrics gene chip system according to manufacturer's instructions.
RT ± PCR
Reverse transcription-PCR (RT ± PCR) was performed on total RNA prepared by the Tri Reagent method. 7.5 mg of RNA were employed for cDNA synthesis using M-MLV reverse transcriptase (Promega, 200 u) and oligo dT (0.5 mg, Pharmacia). PCR was performed on 1 ml of the 20 ml cDNA sample. Below are indicated, respectively, the number of cycles and the sequences of 5' and 3' primers used for each of the tested genes: for the gene encoding RPA2, 30 cycles, using 5'-CCGGATCCGCAAGAGCCCGAGCC-CAGC-3' and 5'-CGGAATTCGCACGGTGAGGCCATTT-GCTGGC-3'; for the gene encoding glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 19 cycles using 5'-ACCA-CAGTCCATGCCATCAC-3' and 5'-TCCACCACCCTG-TTGCTGTA-3'. The annealing temperature for both genes was 508C. For the gene encoding topoisomerase II a, 26 cycles, using 5'-CAATGCTCAGCCCTTTGGCTCG-3' and 5'-GTAGTCCCACTCTCTCTGCC-3'; for the gene encoding DNA polymerase a subunit IV, 26 cycles, using 5'-CACAACACAGTGAAGCTGGG-3' and 5'-GGGTGAA-CACTAAAAGGGC-3'. The annealing temperature for both genes was 588C.
Northern blot analysis
RNA was extracted from cells by the Tri Reagent method. Twenty mg of total RNA from each sample were separated on a formaldehyde gel and then blotted to GeneScreen Plus membrane (DU PONT) according to manufacturer's instructions. Acidic Ribosomal Protein (ARPP PO) was used as a control probe.
Cell-cycle flow cytometry assays
Bromodeoxyuridine (BrdU, ®nal concentration, 10 mM) was added to cells 30 min prior to harvesting. Cells were trypsinized and ®xed with 70% ethanol (720). After ®xation, cells were centrifuged for 5 min at 1200 r.p.m. and incubated for 30 min at room temperature in 1 ml of 2 M HCl/0.5% Triton X-100. After recentrifugation, cells were washed with 1 ml of 0.1 M Na 2 B4O7 (pH 8.5) and reacted with anti BrdU antibody (Becton Dickinson, 347580, 15 ml per test) and then with Fluorescein isothiocyanate-conjugated anti mouse antibody. Then cells were resuspended in PBS containing 5 mg/ml propidium idodide for 30 min at room temperature. Fluorescence intensity was analysed on a Becton Dickinson¯ow cytometer.
5' Rapid amplification of cDNA ends (5' RACE)
Total RNA was extracted from growing MCF-7 cells using Tri Reagent method and subjected to 5'-race analysis according to the manufacture instructions (Gibco ± BRL, 18374-058). The primer used for the ®nal step of ampli®ca-tion of the 5' end of human RPA2 mRNA was 5'-GGGAATTCGCGCTTAGTACCATGTGTGC-3'.
Isolation of human RPA2 promoter
A 682 bp fragment of the RPA2 promoter from the +55 to 7627 was generated by PCR using 100 ng human genomic placenta DNA as template and 60pm each from the 5' and 3' primers: 5'-CGGGGTACCGGATGAGACTGGGATG-GGG-3' and 5'-CGGAAGCTTCCACTGCGCCGCTCT-GGC-3'.
Plasmids
The luciferase reporter plasmid RPA2(7627/+55) Luc was constructed by subcloning the 682 bp KpnI/HindIII fragment of the RPA2 promoter in PA3Luc. Mutation in the E2F DNA binding sites were generated by PCR-sitedirected mutagenesis which changed TTTGGCGC(7320 to 313) to TTTGAAGC, GTTCGCGC(7309 to 7316) to GTTCGCTT, TTTGGAGC(7125 to 7118) to TTTGAAGC to generate RPA2(mut)Luc. pCMV-b-Gal, pCMV-E2F-1 and pCMV-DP1 were described previously (Krek et al., 1993; Lindeman et al., 1997) .
Transfection assay
H1299 cells were transfected by the calcium phosphate method. Cells were harvested 42 h after transfection, and lysates were tested for luciferase and b-galactosidase activities as described previously (Lindeman et al., 1997) .
